Evidence reviews
Evidence reviews 2019
The following documents contain the evidence that was used to develop the recommendations:
- Accessibility and sustainability of abortion services
- Information needs of women undergoing an abortion
- Anti-D prophylaxis for women up to 13+6 weeks’ gestation (replaced with supporting document Q for the recommendations on anti-D prophylaxis)
- Antibiotic prophylaxis for medical and surgical abortion
- VTE prophylaxis for women having abortion
- Abortion before ultrasound evidence
- Expulsion at home for early medical abortion
- Simultaneous versus delayed mifepristone + misoprostol administration for medical abortion up to 10+0 weeks’ gestation
- Follow-up after medical abortion up to 10+0 weeks
- Misoprostol after mifepristone for inducing medical abortion between 10+1 and 24+0 weeks’ gestation
- Medical versus surgical abortion between 13+0 and 24+0 weeks’ gestation
- Medical abortion after 24 weeks’ gestation
- Cervical priming before surgical abortion
- Anaesthesia or sedation for surgical abortion
- Support after abortion
- Contraception after abortion
Other supporting evidence
This page was last updated: